Additional assistance necessary for patients prescribed specialty therapies.
Julia Laurin
Advertisement
Articles by Julia Laurin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Report: Richard Pazdur Out as Director of CDER
4
Patients Avoid Care as Healthcare Costs Rise: Report
5
